Quantifying the Benefits and Risks of Methylphenidate as Treatment for Childhood Attention-Deficit/Hyperactivity Disorder.

Quantifying the Benefits and Risks of Methylphenidate as Treatment for Childhood Attention-Deficit/Hyperactivity Disorder.

JAMA. 2016 May 10;315(18):1953-1955

Authors: Shaw P

PMID: 27163984 [PubMed – as supplied by publisher]

via http://www.ncbi.nlm.nih.gov/pubmed/27163984?dopt=Abstract